TransMedics Group, Inc. (TMDX)
Company Info
Highlights
$4.35B
$1.41
91.22
$488.23M
$290.25M
$82.66M
$55.00 - $177.37
$126.71
44.92%
7.49
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
TransMedics Group, Inc. (TMDX) returned 104.80% year-to-date (YTD) and -10.27% over the past 12 months.
TMDX
104.80%
38.15%
46.58%
-10.27%
62.26%
57.42%
N/A
^GSPC (Benchmark)
0.52%
6.32%
-1.44%
12.25%
12.45%
14.20%
10.84%
Monthly Returns
The table below presents the monthly returns of TMDX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 8.34% | 12.98% | -11.84% | 36.76% | 38.78% | 104.80% | |||||||
| 2024 | 8.67% | -4.86% | -9.39% | 27.31% | 44.91% | 10.43% | -5.55% | 18.14% | -6.58% | -47.79% | 5.78% | -28.09% | -21.01% |
| 2023 | 2.11% | 27.05% | -5.42% | 4.45% | -8.14% | 15.58% | 10.95% | -29.57% | -16.58% | -31.54% | 101.92% | 4.29% | 27.88% |
| 2022 | -17.17% | 16.70% | 45.46% | -22.20% | 39.17% | 7.82% | 28.39% | 28.85% | -19.78% | 15.52% | 28.31% | -0.24% | 222.13% |
| 2021 | 14.47% | 57.55% | 15.60% | -30.80% | -10.69% | 29.41% | -14.04% | 14.59% | 1.25% | -17.10% | -19.65% | -13.07% | -3.72% |
| 2020 | -7.89% | -10.34% | -23.06% | 49.75% | -26.98% | 35.65% | 0.78% | -1.27% | -22.71% | -13.06% | 24.12% | 33.83% | 4.68% |
| 2019 | 21.60% | 6.62% | -18.14% | 0.93% | -0.84% | -24.46% | 4.52% | 1.39% | -14.98% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of TMDX is 44, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for TransMedics Group, Inc. (TMDX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the TransMedics Group, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the TransMedics Group, Inc. was 73.69%, occurring on Feb 23, 2022. Recovery took 113 trading sessions.
The current TransMedics Group, Inc. drawdown is 27.49%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -73.69% | Mar 23, 2021 | 234 | Feb 23, 2022 | 113 | Aug 5, 2022 | 347 |
| -67.79% | Aug 28, 2024 | 99 | Jan 21, 2025 | — | — | — |
| -65.47% | May 23, 2019 | 205 | Mar 16, 2020 | 228 | Feb 9, 2021 | 433 |
| -61.76% | Jul 19, 2023 | 73 | Oct 30, 2023 | 124 | Apr 29, 2024 | 197 |
| -29.9% | Sep 13, 2022 | 24 | Oct 14, 2022 | 15 | Nov 4, 2022 | 39 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of TransMedics Group, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of TransMedics Group, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 190.1% positive surprise.
Valuation
The Valuation section provides an overview of how TransMedics Group, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for TMDX, comparing it with other companies in the Medical Devices industry. Currently, TMDX has a P/E ratio of 91.2. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for TMDX relative to other companies in the Medical Devices industry. Currently, TMDX has a P/S ratio of 8.9. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for TMDX in comparison with other companies in the Medical Devices industry. Currently, TMDX has a P/B value of 16.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |